Medications

New drug candidate blocks resistance to cancer therapies

A team of researchers at the University of Michigan Health Rogel Cancer Center has designed a molecule that impairs signaling mediated by two key drivers of cancer therapy resistance. The design and preclinical evaluation ...

page 1 from 2